Avero Diagnostics, a physician-owned laboratory based in Dallas, is now providing molecular testing for covid-19. To help prevent the spread of this disease, Avero will be supporting the diagnostic needs of area hospitals, health systems, multispecialty family practices, urgent care centers, and county health departments.
“For the protection of our community, it’s imperative that testing be made available to people who are symptomatic or have been exposed to someone with covid-19,” says Trae Mattison, MD, managing partner of Avero Diagnostics. “Within the United States, covid-19 testing also plays a critical role in each region’s ability to meet federal guidelines for reopening. Avero Diagnostics is working to coordinate with regional officials to ensure our lab is added to the official testing capacity for the region, support the demands of the local healthcare community, and help alleviate the current testing shortfall.”
Once a healthcare provider orders a test and collects the required specimen, couriers will transport patient samples from designated sites to be processed through Avero Diagnostics’ CLIA-certified and CAP-accredited laboratory, where diagnostic testing will be run on the Hologic Panther platform using the transcription-mediated amplification version of Hologic’s SARS-CoV-2 assay.
Avero Diagnostics can initially process approximately 500 test kits per day, with plans to scale up capacity based on demand, and expects to provide results to ordering physicians within 24 to 48 hours.
For more information, visit Avero Diagnostics.
